BUZZ-U.S. Stocks on the Move-Novogen, Tetralogic, oil companies, BBX, Cyclacel, Talisman

Tue Dec 16, 2014 1:02pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stocks rose in a volatile Tuesday session as energy shares rallied and investors bet the Federal Reserve will be cautious in removing support in the face of a more fragile global economy.

The Dow Jones industrial average was up 0.64 percent at 17,290.27, the S&P 500 was up 0.56 percent at 2,000.78 and the Nasdaq Composite was up 0.20 percent at 4,614.425.

** NOVOGEN LTD, $4.91, +187.13 pct

The Australian drug developer said its brain cancer drug, TRXE-009, was also found to be effective in treating a kind of skin cancer in pre-clinical studies.


The drug developer lowered dosage of ovarian cancer drug in early-stage study after adverse events were reported. The drug, tested in combination with Amgen's conatumumab, led to adverse events at doses lower than expected.